Zobrazeno 1 - 10
of 101
pro vyhledávání: '"CongXin Dai"'
Autor:
Wentai Zhang, Dewei Zhang, Shaocheng Liu, He Wang, Xiaohai Liu, Congxin Dai, Yi Fang, Yanghua Fan, Zhenqing Wei, Ming Feng, Renzhi Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
PurposeNo multi-center radiomics models have been built to predict delayed remission (DR) after transsphenoidal surgery (TSS) in Cushing’s disease (CD). The present study aims to build clinical and radiomics models based on data from three centers
Externí odkaz:
https://doaj.org/article/0d4c8ee7aacc47bfb33018304c84c66d
Autor:
Binghao Zhao, Yu Xia, Fengchun Yang, Yaning Wang, Yuekun Wang, Yadong Wang, Congxin Dai, Yu Wang, Wenbin Ma
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-17 (2022)
Abstract Background IDH-mutant astrocytoma and oligodendroglioma have an indolent natural history and are recognized as distinct entities of neoplasms. There is little knowledge on the molecular differences between IDH-mutant astrocytoma and oligoden
Externí odkaz:
https://doaj.org/article/635748237f23445980f01cff14fe0e02
Autor:
Congxin Dai, Bowen Sun, Shusen Guan, Wei Wang, Honggang Liu, Yong Li, Jialiang Zhang, Jun Kang
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Pituitary carcinomas (PCs), defined as distant metastases of pituitary neoplasms, are very rare malignancies. Because the clinical presentation of PCs is variable, early diagnosis and management remain challenging. PCs are always
Externí odkaz:
https://doaj.org/article/122bb7ce1f4c462e84ae2443ddb8a4c7
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/7f555237646b41d2b35c1c3b13143280
Autor:
Xiaohai Liu, Congxin Dai, Xinjie Bao, Kan Deng, Yong Yao, Ming Feng, Mingchu Li, Ge Chen, Renzhi Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMost of pituitary adenomas (PAs) are slow-growing benign tumors which can be cured or controlled by conventional therapies, including surgery, medical treatment or radiotherapy. A small set of PAs, usually known as aggressive PAs or refract
Externí odkaz:
https://doaj.org/article/1a22b6b45f004831b57bf4fb9f7ae2d4
Autor:
Congxin Dai, Ming Feng, Lin Lu, Bowen Sun, Yanghua Fan, Xinjie Bao, Yong Yao, Kan Deng, Renzhi Wang, Jun Kang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTranssphenoidal surgery (TSS) is the first-line treatment for corticotroph adenomas. Although most corticotroph adenomas are noninvasive microadenomas, a small subset of them invading cavernous sinus (CS) is notoriously difficult to manage.
Externí odkaz:
https://doaj.org/article/99639f55651d433588973719589000a2
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Pituitary adenomas (PAs) are a group of tumors with complex and heterogeneous clinical manifestations. Early accurate diagnosis, individualized management, and precise prediction of the treatment response and prognosis of patients with PA are urgentl
Externí odkaz:
https://doaj.org/article/b827ceebbd594004a9806b781e7d85b3
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Most pituitary tumors are considered benign adenomas, and only 0.1%–0.2% of them present metastasis and are defined as pituitary carcinomas (PCs). Refractory pituitary adenomas (PAs) lie between benign adenomas and true malignant PCs and are define
Externí odkaz:
https://doaj.org/article/8fe4900f61c6430098f966006066a7df
Autor:
Yaning Wang, Wenlin Chen, Tianrui Yang, Binghao Zhao, Lizhou Zhou, Ziren Kong, Yuekun Wang, Congxin Dai, Yu Wang, Wenbin Ma
Publikováno v:
Brain and Behavior, Vol 11, Iss 11, Pp n/a-n/a (2021)
Abstract Introduction Prognostic situations differ in patients with malignant intracranial tumors. We focused on the quality of life, ability of daily living, and cognitive function of patients in the perisurgery period and investigated the correlati
Externí odkaz:
https://doaj.org/article/4315bef87e244358ad44376953da5ed4
Autor:
Ziren Kong, Yusong Lin, Chendan Jiang, Longfei Li, Zehua Liu, Yuekun Wang, Congxin Dai, Delin Liu, Xuying Qin, Yu Wang, Zhenyu Liu, Xin Cheng, Jie Tian, Wenbin Ma
Publikováno v:
Cancer Imaging, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter has emerged as a favorable independent prognostic and predictive biomarker in glioma. This study aimed to build a radiomics signature based on 18
Externí odkaz:
https://doaj.org/article/05a98888287b42beb5971e0ea338f48c